Ovid Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $10.8M | $80.8M | $41.9M |
| FY2020 | $32.3M | $75.9M | $72.0M |
| FY2021 | $14.8M | $194.5M | $187.8M |
| FY2022 | $23.0M | $155.3M | $44.9M |
| FY2023 | $56.2M | $144.0M | $27.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $10.8M | $80.8M | $41.9M |
| FY2020 | $32.3M | $75.9M | $72.0M |
| FY2021 | $14.8M | $194.5M | $187.8M |
| FY2022 | $23.0M | $155.3M | $44.9M |
| FY2023 | $56.2M | $144.0M | $27.0M |